Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.